Evidence map›Paper›PMID 30122214›Full record

ArticleAmerican journal of preventive medicine2018

Cost-Effectiveness Analysis of The Real Cost Campaign's Effect on Smoking Prevention.

Anna J MacMonegle, James Nonnemaker, Jennifer C Duke, Matthew C Farrelly, Xiaoquan Zhao, Janine C Delahanty, Alexandria A Smith, Pamela Rao, Jane A Allen

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Health educationFrontiers in public health · 2022
    Article
  11. Theory-Based Social and Non-Social Engagement Features in Smoking Cessation Mobile Apps: A Content Analysis.International journal of environmental research and public health · 2021
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna J MacMonegleRTI International, Research Triangle Park, North Carolina. Electronic address: amacmonegle@rti.org.
James NonnemakerRTI International, Research Triangle Park, North Carolina.
Jennifer C DukeRTI International, Research Triangle Park, North Carolina.
Matthew C FarrellyRTI International, Research Triangle Park, North Carolina.
Xiaoquan ZhaoCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland; Department of Communication, George Mason University, Fairfax, Virginia.
Janine C DelahantyCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland.
Alexandria A SmithCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland.
Pamela RaoCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland; Akira Technologies, Washington, District of Columbia.
Jane A AllenRTI International, Research Triangle Park, North Carolina.

Funding

FDA HHS HHSF223201310001B
6 · The paper itself

Abstract

introductionA previous study found that the Food and Drug Administration's The Real Cost national tobacco education campaign was associated with preventing approximately 350,000 U.S. youth from initiating smoking between 2014 and 2016. This study translates the reduction in smoking initiation into monetary terms by examining the cost effectiveness of the campaign.

methodsThe cost effectiveness of The Real Cost was assessed by measuring efficiency in two ways: (1) estimating the cost per quality-adjusted life year saved and (2) estimating the total monetary return on investment by comparing the cost savings associated with the campaign to campaign expenditures. Analyses were conducted in 2017.

resultsThe Real Cost averted an estimated 175,941 youth from becoming established smokers between 2014 and 2016. Campaign expenditures totaled $246,915,233. The cost per quality-adjusted life year saved of the campaign was $1,337. When considering the costs of smoking, the averted established smokers represent >$31 billion in cost savings ($1.3 billion when only external costs considered). The overall return on investment of the campaign was $128 in cost savings for every $1 spent ($4 for every $1 spent when only external costs considered). These conclusions were robust to sensitivity analyses surrounding the parameters.

conclusionsCampaign expenditures were cost efficient. The cost savings resulting from The Real Cost represent a large reduction in the financial burden to individuals, their families, and society as a result of tobacco. Public health campaigns, like The Real Cost, that reduce tobacco-related morbidity and mortality for a generation of U.S. youth also provide substantial cost savings.

Indexed as

Cost-Benefit AnalysisAdolescentCost SavingsFemaleHealth PromotionHumansMalePublic HealthQuality-Adjusted Life YearsSmokingSmoking PreventionUnited States

Identifiers

PMID30122214
PMCPMC13374720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.